Patent for Klaria’s Sumatriptan Alginate Film Granted in Russia
Klaria’s patent for Sumatriptan Alginate Film has been granted in Russia. This grant extends the global patent protection for Klaria’s most advanced development program. The period of patent protected exclusivity in the Russian Federation will last until 2037.UPPSALA, 10 February, 2021. The granted Sumatriptan Alginate Film patent protects the combination of the active substance, Sumatriptan, with the Alginate Film. The period of patent protected exclusivity in Russian will last until 2037. This granting of the Sumatriptan Alginate Film patent is the third granting of this patent world-